June 19, 2009

Seroquel Class Action MDL: Ruling on General Causation

Plaintiffs who filed Seroquel lawsuits finally got some good – albeit expected – news. Seroquel’s manufacturer will not be able to bar medical testimony on general causation of the link between Seroquel and weight gain and diabetes, a federal judge ruled.

Plaintiffs’ lawyers’ expert on Seroquel, the chairwoman of the epidemiology department at the University of Alabama at Birmingham, is expected to opine that Seroquel causes metabolic changes which can lead to diabetes without weight gain.

Honestly, I cannot imagine a scenario where general causation would be an issue. There really is not much legitimate dispute. The challenge that Plaintiffs’ Seroquel lawyers have had in the lawsuits that have gone forward is specific causation, whether diabetes was caused in the Plaintiff, as opposed to the general principle that Seroquel can cause diabetes.

As American Law Litigation Daily pointed out on Monday, Delaware Superior Court Judge Joseph Slights was pretty discouraging about the future of the Seroquel lawsuits in his recent opinion. The judge pointed out that in every Seroquel lawsuit, plaintiffs’ experts have been bounced on Daubert grounds. But you have to look at the facts of those specific cases (here and here). While plaintiffs’ Seroquel lawyers might have thought these were good cases to push forward, it is pretty clear that these were bad cases on the facts (it could have evolved that way in a way unknown to plaintiffs’ Seroquel lawyers.)

There are still 13,000 Seroquel lawsuits out there. There is a long way to go.

August 27, 2008

James Publishing: Insurance Settlements

My two volume treatise Insurance Settlements is now available from James Publishing. The book discusses how to position a lawyer's car accident, truck accident, medical malpractice or product liability case to the best possible settlement at every step along the way (until the state's high court affirms the judgment).

Click on the James Publishing link. If you have any comments on the book, please email me at ronmiller@millerandzois.com under the subject "Insurance Settlements Comments."

August 22, 2008

Alabama Lawyers for the Indigent

Dennis Sherer had a good article on Tuesday in the Times Daily about Alabama Chief Justice Sue Bell Cobb concern that the lawyers representing the poor in Alabama receive provide quality legal representation. Justice Cobb would like the state of Alabama to fund an oversight committee to ensure the legal interests of poor defendants and state taxpayers.

Tennessee does what is clear a dumb thing: lawyers receive $40 per hour for work on indigent cases outside of court and $60 for work inside the court. (This is mostly in criminal cases. The paradigm of accident and malpractice cases does not require clients to pay fees before a recovery.) Lawyers obviously cannot run a law practice on this so the lawyers are allowed to bill the state for their overhead. Not a bad idea in utopia but an awful idea in the real world. Justice Cobb wants to change this system. I hope she can.

August 20, 2008

Byetta Lawyer: Potential Lawsuits and Settlements involving Byetta

Our lawyers are reviewing Byetta claims after the FDA announced this week that the diabetes drug has been linked to severe pancreatic problems in dozens of patients. On Monday, the FDA warned patients taking Byetta to discontinue use if they develop symptoms of the disorder. Further the FDA said that doctor prescribing Byetta should consider other prescription options for patients with a history of pancreas problems.

Since Byetta was introduced into the United States in 2005, more than 700,000 patients have used the Byetta.

Our lawyers are now exploring potential Byetta lawsuits. If you would like to discuss your case with a Byetta lawyer, call 800-553-8082 or click here for a free consulation/case evaluation (or even to answer any question you may have). For more information on Byetta and the concerns with Byetta, click here.

August 13, 2008

Digitek Manufacturer Recalls More Drugs

Last week, Digitek manufacturer Actavis Totowa recalled over 65 different drugs made at their New Jersey manufacturing plant. The list of recalled drugs (in some form or another) includes such generic drugs as Bellamine, Buspirone, Carisoprodol, Oxycodone Meperidine, and Rifampin. This strengthens the conclusion that the New Jersey plant that made these drugs may be the cause of irregularities in Actavis medications.

In April 2008, Actavis recalled Digitek, a drug prescribed to treat heart failure and irregular heartbeat because it was discovered that Digitek tablets appeared to have double the thickness – and likely double the active ingredient – listed on the label. When Digitek is given in abnormally high doses it can lead to digitalis toxicity which, paradoxically, worsens the problems Digitek is intended to treat, causing nausea or lower blood pressure and other side effects from the Digitek overdose that can lead to the increased risk of stroke or a heart attack.

If you would like to speak to a Digitek recall lawyer about a potential Digitek lawsuit, call 1-800-553-8000. For more information on the Digitek overdose recall or a free consultation on your potential Digitek case, click here.

August 12, 2008

Zimmer Durom Cup Hip Implant Lawsuits

Zimmer's Durom Cup hip implants are likely to be the subject of a good number of lawsuits from patients with the Zimmer implants. But they will not be the only ones. Apparently, Zimmer’s own shareholders may agree that Zimmer left its hip implant on the market way too long. Last week, shareholders of Zimmer stock filed a class action in Indiana. Interestingly, the lawsuit seeks damages for shareholders who purchased stock between January 28, 2008 and July 21, 2008. This tells our Zimmer hip implant recall lawyers that these shareholders believe that Zimmer knew or should have known and issued a recall on or before January 28, 2008.

If your Zimmer Durom hip resurfacing cup was defective, call our Zimmer hip implant lawyers at 1-800-553-8082 or click here for a free consultation.

More information on the Zimmer Hip Implant Recall
History of the Zimmer Durom Cup Hip Implant Recall
More information on the Zimmer hip implant recall lawsuits

August 11, 2008

Rotator Cuff Injury Lawyers

Jury Verdict Research(r) study reports that rotator cuff injuries reached a 7-year high in 2006 with a compensatory award median of $72,667. This is almost 50% higher than previous reported settlements and verdicts in rotator cuff injury cases.

Our lawyers have never understood while the national data in these cases was so low. Washington D.C. rotator cuff injuries have averaged well over $100,000 for rotator cuff settlements and verdicts so we have never understood why the national average was as low as it has been. In any event, for whatever reason, rotator cuff verdicts are on the rise.

Our lawyers handle rotator cuff injury cases throughout the United States. Our lawyers have handled scores of rotator cuff injuries in car and truck accidents, typically in side collision or "T-bone" accidents. Our lawyers believe that insurance companies do not give fair value in most rotator cuff injury cases and our lawyers will fight to get you the financial compensation you deserve. Call a rotator cuff lawyer to protect you at 800-553-8082 or click here for a free consultation and case evaulation.

Related Posts

What Is the Value of Your Personal Injury Claim? (how the value of rotator cuff and other person injury settlements are calculated)

Sample Demand Letter (sample letter demanding settlement in a personal injury case)

Handling Your Claim Without a Lawyer (tips and pratfalls)

July 14, 2008

Digitek Lawsuits

Lawyers representing Digitek overdose victims have filed nine lawsuits in New Jersey against Actavis Totowa LLL and its parent company Actavis Group, alleging a manufacturing defect in Digitek, namely that some Digitek tablets have contained twice the active ingredient of the drug. Digitek recall lawsuits have also been filed in West Virginia and California.

Our Digitek recall lawyers are reviewing these Digitek overdose cases in all 50 states expecting that a consolidated class action lawsuit will be appropriate (as opposed to this scatting of individual cases). If you want to discuss your case with one of our Digitek lawyers call us at 800-553-8082 for a free consultation or click here for a free Internet consultation.


July 7, 2008

Three Alabama Medical Malpractice Cases

The Alabama Supreme Court has decided three medical malpractice cases in the last few months: Giles v. Brookwood Health Services, Weber v. Freeman, and Panayiotou v. Johnson. All three were decided in favor of the defendant doctor. All three take the decision as to who was at fault for the plaintiffs’ injuries/death out of the hands of the jury. I thought the Alabama medical malpractice lawyers in all three cases made quality arguments that the cases should go to a jury.

Giles was a complicated case involving three defendants. What I found frustrating about the opinion is that the court essentially told the Plaintiff’s expert that “you really say what you think you said” about the standard of care. Why take this kind of medical malpractice case out of a jury's hands?

Weber involved a nice Alabama rule to allow medical malpractice lawyers to name fictional defendants when the lawyer does not know who the real defendants are. Alabama Rule 9(h), Ala. R. Civ. P., provides:

"When a party is ignorant of the name of an opposing party and so alleges in the party's pleading, the opposing party may be designated by any name, and when that party's true name is discovered, the process and all pleadings and proceedings in the action may be amended by substituting the true name."

Great rule. So the question in the case hinged on whether Plaintiff’s medical malpractice lawyer was “ignorant" of the identity of two of the defendants.

The Plaintiff’s lawyer argued that the substitution should be permitted, because she says when she filed her original complaint, she was unaware of the hospitals’ protocol requiring radiologists to notify emergency-room personnel if they discovered a life-threatening condition in a patient who had left the emergency room. But the court said the lawyers were not "ignorant" of a relationship that gave rise to a duty and that they knew that the identity of the health care providers. Accordingly, given the facts of this case, there was a reasonable, good-faith basis for counsel to have named the doctor in the original complaint and the lawyer’s failure to do so fatally bars the medical malpractice claim.

That’s cutting it real thin, particularly when the Alabama court went in a different direction one year before in Ex parte Bowman which arguably was factually similar. These lawyers did the right thing not suing everyone in sight and this is the thanks that they get.

In Panayiotou, the Alabama court overruled the Mobile Circuit Court in finding that a doctor did not have the necessary subspecialty to offer expert opinions. This is an awful ruling for two reasons. First, as the dissent points out, the plaintiff’s expert had experience similar to or greater than the defendant doctor. Doesn’t this count for something? Even more unfairly, the Alabama court is clearly making new Alabama law. Fine. But is it fair to spring a new rule on the Plaintiff in this case? Wouldn’t justice remand to the trial court with instructions to allow Plaintiff’s lawyer to find a new expert who meets this new standard?

Alabama, famously called a “judicial hellhole,” has taken a lot of heat by tort reform advocates Are these judges, elected by the voters, responding to this pressure and the pressure from campaign contributors who support insurance companies? Who knows? But I can tell you I think they made unjust calls in all three of these cases.

July 2, 2008

Alabama Jury Orders GlaxoSmithKline and Novartis to pay $114 million

An Alabama jury on Tuesday ordered drug companies GlaxoSmithKline and Novartis to pay a combined $114 million in damages for their involvement in a Medicaid price fixing scheme. Lawyers for the state of Alabama claimed these drug manufacturers charged higher prices to Medicaid than those offered to other companies. In other words, they were trying to rip off the government. (If true, they would not be the first.)

Alabama has been out on the forefront of policing drug companies on this issue. Alabama has accused 70 drug companies with Medicaid drug pricing fraud. In the trial with AstraZeneca Pharmaceuticals in February, a jury awarded $115 million (later reduced to $160 million).

In the public relations battles between drug companies and injury victims, one thing often gets left out: these drug companies are getting called to the mat for their reckless pursuit of profits by more than just drug injury lawyers.

December 21, 2007

Welcome to Our Blog

Welcome to our blog covering injury law and policy throughout the United States.